Please Wait
Applying Filters...
menu
    • menu
    Default Key Product, Service and Excipients
    News
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis

    08 May 2024

    // PRESS RELEASE

    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate

    08 Apr 2024

    // PRESS RELEASE

    Tiefenbacher Group awarded the EcoVadis Silver Medal!

    19 Mar 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Tiefenbacher Group

    Contact Supplier

    Website

    BMWS24

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
    Menu

    Tiefenbacher API + Ingredients GmbH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-89424.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-96648.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    R&D API Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-97507.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Veterinary API Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-987.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis

    08 May 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/05/08/tiefenbacher-api-ingredients-offers-custom-synthesis-of-intermediates-apis/

    PRESS RELEASE
    08 May 2024
    Share Share
    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate

    08 Apr 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/04/08/tiefenbacher-group-welcomes-new-coo-sandip-tarate/

    PRESS RELEASE
    08 Apr 2024
    Share Share
    Tiefenbacher Group awarded the EcoVadis Silver Medal!
    Tiefenbacher Group awarded the EcoVadis Silver Medal!

    19 Mar 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/03/19/tiefenbacher-group-awarded-ecovadis-silver-medal/

    PRESS RELEASE
    19 Mar 2024
    Share Share
    Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
    Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide

    27 Sep 2023

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2023/09/27/launch-tiefenbacher-pharmaceuticals-generic-version-teriflunomide/

    PRESS RELEASE
    27 Sep 2023
    Share Share
    Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority
    Successful Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority

    10 May 2023

    // PRESS RELEASE

    https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/

    PRESS RELEASE
    10 May 2023
    Share Share
    Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine
    Tiefenbacher Pharma Successfully Launches The Antihistamine Bilastine

    14 Mar 2023

    // PRESS RELEASE

    https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/

    PRESS RELEASE
    14 Mar 2023
    Share Share